🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Inuvair® is a novel fixed combination product used in the treatment of asth...
Status
Unknown
Location
University Hospitals Leuven
Start Date
2011-11
Trial ID
NCT01466712
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
The primary objectives of this study are to assess bronchodilator efficacy ...
Status
Terminated
Location
1184.14.01013 Boehringer Ingelheim Investigational Site
Start Date
2008-04-15
Trial ID
NCT00662740
The purpose of this study is to further figure out differences of glycopyrr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-08
Trial ID
NCT01922271
Treatments Being Tested
This is a randomised, double-blind, double-dummy, multinational, multicentr...
Status
Completed
Location
205.389.1020 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00563381
Treatments Being Tested
This is a multiple dose, randomized, parallel, double-blind, double-dummy, ...
Status
Completed
Location
Research Site
Start Date
2016-07-05
Trial ID
NCT02796677
This is a Phase IV multi-center, randomized, open-label, cross-over, placeb...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-21
Trial ID
NCT02786927
A randomized, placebo-controlled, double-blind, parallel group, multi cente...
Status
Completed
Location
205.477.001039 Boehringer Ingelheim Investigational Site
Start Date
2012-08-01
Trial ID
NCT01663987
Treatments Being Tested
The primary purpose of this study is to evaluate lung function and health r...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-25
Trial ID
NCT03478696
This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-03
Trial ID
NCT00846586
Treatments Being Tested